Evidence that a synthetic amyloid-ß oligomer-binding peptide (ABP) targets amyloid-ß deposits in transgenic mouse brain and human Alzheimer's disease brain

From National Research Council Canada

DOIResolve DOI: https://doi.org/10.1016/j.bbrc.2014.02.064
AuthorSearch for: 1; Search for: 1; Search for: 1; Search for: 1; Search for: 1; Search for: 1; Search for: 1
Affiliation
  1. National Research Council of Canada. Human Health Therapeutics
FormatText, Article
Subjectamyloid beta protein; amyloid beta protein[1-42]; amyloid beta protein[25-35]; oligomer; synthetic peptide; Alzheimer disease; animal experiment; animal model; animal tissue; apoptosis; brain; brain cortex; brain tissue; hippocampus; human tissue; immunohistology; microinjection; mouse; neuroblast; nucleotide sequence; protein aggregation; protein targeting; transgenic mouse; Mus musculus; AD transgenic mice; Alzheimer's disease; Amyloid binding peptide; Aβ(1-42) oligomers; Human AD brains; PCM-1 protein; Aged; Aged, 80 and over; Alzheimer Disease; Amino Acid Sequence; Amyloid beta-Peptides; Autoantigens; Brain; Cell Cycle Proteins; Cell Line; Male; Mice; Mice, Transgenic; Middle Aged; Molecular Sequence Data; Peptide Fragments; Peptides; Protein Binding
Abstract
Publication date
In
LanguageEnglish
Peer reviewedYes
NPARC number21272242
Export citationExport as RIS
Report a correctionReport a correction (opens in a new tab)
Record identifier99784d6c-3fd9-4e99-9772-3d13f62a4021
Record created2014-07-23
Record modified2020-04-22
Date modified: